Limbaroc, Jenny A.
HRN: 26-25-33 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/24/2024
CEFUROXIME 1.5GM (VIAL)
11/24/2024
11/30/2024
IV
1.5g
Q8h
Primary LTCS With Intraop IUD
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes